Correlation Between Nuvectis Pharma and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Atea Pharmaceuticals, you can compare the effects of market volatilities on Nuvectis Pharma and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Atea Pharmaceuticals.
Diversification Opportunities for Nuvectis Pharma and Atea Pharmaceuticals
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nuvectis and Atea is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Atea Pharmaceuticals
Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 3.77 times more return on investment than Atea Pharmaceuticals. However, Nuvectis Pharma is 3.77 times more volatile than Atea Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about 0.19 per unit of risk. If you would invest 487.00 in Nuvectis Pharma on October 15, 2024 and sell it today you would earn a total of 94.00 from holding Nuvectis Pharma or generate 19.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvectis Pharma vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Nuvectis Pharma |
| Atea Pharmaceuticals |
Nuvectis Pharma and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and Atea Pharmaceuticals
The main advantage of trading using opposite Nuvectis Pharma and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |